feed,title,long_url,short_url
Benzinga,Genmab/AbbVie's Blood Cancer Treatment Shows 82% Response Rate In Pretreated Follicular Lymphoma Patients,https://benzinga.com/general/biotech/23/06/33037640/genmababbvies-blood-cancer-treatment-shows-82-response-rate-in-pretreated-follicular-lymphoma-pat,https://da.gd/TnhAd
